Commercializing Living Therapies with CCRM
Commercializing Living Therapies with CCRM
Latest Episodes
From qubits to CGTs: Quantum computing’s potential in advanced therapies
Featuring:Alán Aspuru-Guzik, PhD, Director, Acceleration Consortium, Professor of Chemistry, Professor of Computer Science, Professor of Chemical Engineering and Applied Chemistry, Professor of Materials Science and Engineering, Faculty ...
Breaking down barriers: Bringing advanced therapies to patients worldwide
Featuring: Bambi Grilley, Professor at Baylor College of Medicine, President-Elect for the International Society of Cell and Gene TherapyStaci Arnold, Professor of Pediatrics at Emory University, and Pediatric Hematologist/On...
The CMC edge: Future-proofing cell and gene therapies for market
Featuring:Katy Spink, President and COO, Managing Partner, Dark Horse Consulting GroupCraig Beasley, Chief Technology Officer (CMC & Device), BlueRock Therapeutics***Chemistry, Manufacturing, and Controls (CMC) i...
Confronting misinformation in the cell and gene therapies field
Featuring:Megan Munsie, PhD, Group Leader, Stem Cell Ethics & Policy, Stem Cell Medicine, Murdoch Children's Research Institute; Prepare Theme Lead, Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW; Professor Emerging Tec...
Convergence, collaboration and commercialization in cell and gene therapies
Featuring:Molly Shoichet, PhD, O.C., O. Ont., FRS, University Professor and Pamela & Paul Austin Chair in Precision & Regenerative Medicine, University of TorontoAudrey Greenberg, MBA, CEO & Founder, AG Capital Advisor...
